Quarterly Transactions Made in Kymera Therapeutics, Inc. (KYMR)
This table provides information about the institutional ownership of Kymera Therapeutics, Inc. (KYMR). The information is specifically focused on institutions that hold shares of Kymera Therapeutics, Inc..
Shares Purchased
Shares Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q3 2021 | 8,648,645 | 2,281,025 | 10,929,670 | 161,239 | 1,669,795 | 1,831,034 | 9,098,636 | |
| Q4 2021 | 2,596,308 | 8,270,748 | 10,867,056 | 699,256 | 498,564 | 1,197,820 | 9,669,236 | |
| Q1 2022 | 4,065,614 | 837,951 | 4,903,565 | 1,618,634 | 1,518,948 | 3,137,582 | 1,765,983 | |
| Q2 2022 | 8,597,968 | 752,967 | 9,350,935 | 3,103,205 | 2,471,478 | 5,574,683 | 3,776,252 | |
| Q3 2022 | 4,056,618 | 4,050,104 | 8,106,722 | 4,297,094 | 436 | 4,297,530 | 3,809,192 | |
| Q4 2022 | 6,480,870 | 1,486,697 | 7,967,567 | 1,954,084 | 0 | 1,954,084 | 6,013,483 | |
| Q1 2023 | 2,009,642 | 804,396 | 2,814,038 | 1,533,452 | 0 | 1,533,452 | 1,280,586 | |
| Q2 2023 | 4,180,855 | 1,110,246 | 5,291,101 | 1,746,830 | 238,417 | 1,985,247 | 3,305,854 | |
| Q3 2023 | 1,552,465 | 326,791 | 1,879,256 | 3,004,550 | 222,040 | 3,226,590 | -1,347,334 | |
| Q4 2023 | 4,853,396 | 6,698,999 | 11,552,395 | 1,977,056 | 4 | 1,977,060 | 9,575,335 | |
| Q1 2024 | 9,022,562 | 7,743,308 | 16,765,870 | 2,642,151 | 0 | 2,642,151 | 14,123,719 | |
| Q2 2024 | 3,477,892 | 850,297 | 4,328,189 | 3,396,137 | 0 | 3,396,137 | 932,052 | |
| Q3 2024 | 3,958,864 | 5,095,727 | 9,054,591 | 3,680,186 | 0 | 3,680,186 | 5,374,405 | |